Patrick Baumhof, PhD


Patrick Baumhof, PhD trained in Chemistry, at the University of Leipzig. His scientific expertise includes chemistry, pharmaceutical sciences and immunology. He joined CureVac in July 2007 when he was responsible for the development and preclinical testing of new formulations for mRNA vaccines and therapeutics. He is inventor of several patents and he co-authored several publications on mRNA technology. Currently he is heading the department for Product design an formulations and is Program manager for the RNAoptimizer Program.